Introducing the Optimum TAV
Designed for durability.
Thubrikar Aortic Valve to Present Promising Initial Results of CE Mark-Enabling Study with Novel Optimum TAV™ at EuroPCR 2023
A conversation on TAV durability
Dr. Jeffrey Popma, Dr. Danny Dvir, and Dr. Mano Thubrikar discuss at the Baim Institute of Clinical Research in Boston
